Patent Assignment
Reel/Frame 017466/0096
Assignment of Assignor's Interest
Recorded: 2006-01-17
Received: 2006-01-19
Pages: 8
Assignor
BIOREXIS PHARMACEUTICAL CORPORATION
Executed: 2005-10-31
Assignee
BIOREXIS TECHNOLOGY, INC.
103 FOULK ROAD, SUITE 202, WILMINGTON, DE, 19803, UNITED STATES
Covered Properties
(18)
Oral Delivery of Modified Transferrin Fusion Proteins
Application:
10/515,232 →
Modified transferin-antibody fusion proteins
Application:
10/515,428 →
Modified transferrin fusion proteins
Application:
10/515,430 →
Transferrin fusion proteins libraries
Application:
10/515,429 →
Transferrin fusion proteins and methods of use
Application:
60/691,229 →
Modified transferrin fusion proteins
Application:
60/663,757 →
Modified transferrin fusion proteins
Application:
60/658,140 →
Modified transferrin fusion proteins
Application:
60/622,147 →
Dipeptidyl-peptidase protected proteins
Application:
60/598,031 →
EPO mimetic peptides and fusion proteins
Application:
60/551,552 →
Transferrin fusion protein libraries
Application:
60/485,404 →
Oral delivery of modified transferrin fusion proteins
Application:
60/460,829 →
Modified transferrin-antibody fusion proteins
Application:
10/384,060 →
Modified Transferrin Fusion Proteins
Application:
10/378,094 →
Modified transferrin fusion proteins
Application:
10/231,494 →
Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
Application:
60/406,977 →
Transferrin fusion proteins
Application:
60/334,059 →
Transferrin fusion proteins
Application:
60/315,745 →